Codexis, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US1920051067
USD
1.77
0.12 (7.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Codexis, Inc. stock-summary
stock-summary
Codexis, Inc.
Specialty Chemicals
Codexis, Inc. is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients. Its CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.
Company Coordinates stock-summary
Company Details
200 Penobscot Dr , REDWOOD CITY CA : 94063-4718
stock-summary
Tel: 1 650 4218100
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 48 Schemes (31.57%)

Foreign Institutions

Held by 58 Foreign Institutions (7.55%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Bernard Kelley
Independent Chairman of the Board
Mr. John Nicols
President, Chief Executive Officer, Director
Dr. Jennifer Aaker
Independent Director
Mr. Thomas Baruch
Independent Director
Ms. Pam Cheng
Independent Director
Mr. Byron Dorgan
Independent Director
Mr. David Smith
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
15 Million
(Quarterly Results - Jun 2025)
Net Profit:
-13 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 221 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.44

stock-summary
Return on Equity

-111.41%

stock-summary
Price to Book

3.98